|
XRCC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.638100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.563600E-02 |
| Normal-vs-Stage2 |
4.020500E-02 |
| Normal-vs-Stage3 |
5.725600E-02 |
| Normal-vs-Stage4 |
3.138400E-02 |
| Stage1-vs-Stage2 |
2.290800E-01 |
| Stage1-vs-Stage3 |
8.014800E-01 |
| Stage1-vs-Stage4 |
3.728800E-01 |
| Stage2-vs-Stage3 |
3.877000E-01 |
| Stage2-vs-Stage4 |
7.806800E-01 |
| Stage3-vs-Stage4 |
4.953600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.176400E-02 |
| Normal-vs-AfricanAmerican |
6.058000E-01 |
| Normal-vs-Asian |
3.232400E-01 |
| Caucasian-vs-AfricanAmerican |
8.986600E-01 |
| Caucasian-vs-Asian |
9.572400E-01 |
| AfricanAmerican-vs-Asian |
9.016000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.382200E-03 |
| Normal-vs-Female |
3.942000E-02 |
| Male-vs-Female |
1.457960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.372020E-01 |
| Normal-vs-Age(41-60Yrs) |
1.781560E-02 |
| Normal-vs-Age(61-80Yrs) |
2.838900E-03 |
| Normal-vs-Age(81-100Yrs) |
7.230600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.607800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.931500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.082200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.636200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.431400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.900200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.991200E-01 |
| Classical-VS-Follicular |
1.20959999794223E-08 |
| Classical-VS-Other |
2.741600E-01 |
| Classical-VS-Normal |
6.187200E-01 |
| Tall-VS-Follicular |
7.32139999959358E-07 |
| Tall-VS-Other |
2.478000E-01 |
| Tall-VS-Normal |
9.831600E-01 |
| Follicular-VS-Other |
5.829800E-01 |
| Follicular-VS-Normal |
1.7721999978626E-08 |
| Other-VS-Normal |
2.434200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.847900E-04 |
| Normal-vs-N1 |
2.963800E-02 |
| N0-vs-N1 |
9.733600E-01 |
|
|
